Korro Bio inks $91.5m Series A
Korro Bio Inc, a RNA therapeutics company, has secured $91.5 million in Series A financing.
Korro Bio Inc, a RNA therapeutics company, has secured $91.5 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination